Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2007-03-13
2007-03-13
Brusca, John S. (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C702S020000, C702S023000
Reexamination Certificate
active
10400005
ABSTRACT:
The invention concerns the identification of proteomes of biological fluids and their use in determining the state of maternal/fetal conditions, including maternal conditions of fetal origin, chromosomal aneuploidies, and fetal diseases associated with fetal growth and maturation. In particular, the invention concerns the identification of the proteome of amniotic fluid (multiple proteins representing the composition of amniotic fluid) and the correlation of characteristic changes in the normal proteome with various pathologic maternal/fetal conditions, such as intra-amniotic infection, or chromosomal defects.
REFERENCES:
patent: 6406921 (2002-06-01), Wagner et al.
patent: 2004/0241775 (2004-12-01), Romero et al.
patent: WO2004/043238 (2004-05-01), None
patent: WO2004/045379 (2004-06-01), None
Vadillo-Ortega et al., Am. J. Obstet. Gynecol., vol. 186, pp. 128-138, Jan. 2002.
Agerberth, B., et al., “FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis”,Proc. Natl. Acad. Sci., USA 3;92(1):195-199, 1995.
Arai, M., et al., “Differential Developmentally Regulated Expression of Gelsolin Family Members in the Mouse”,Dev. Dyn., 215, 297-307, 1999.
Ball, et al., “An integrated approach utilizing artifical neural networks and SELDI mass spectrometry for the classification of human tumors and rapid identification of potential biomarkers”,Bioinformatics18(3):395-404, 2002.
Bejar, R., et al., “Antenatal origin of neurologic damage in newborn infants, I. Preterm Infants”,Am. J. Obstet. Gynecol. 159(2):357-363, Aug. 1988.
Courchesna and Patterson, “Identification of Proteins by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Using Peptide and Fragment Ion Masses”,Methods Mol. Biol. 112(2-D):487-511, 1999.
Creasy, R.K., et al., “Preterm Labor and Delivery”, InMaternal-Fetal Medicine, Creasy, R.K., Resnik, R., (eds.), W. B. Saunders Company, Philadelphia, PA, 4th edition, Chapter 32, pp. 498-531, 1999.
Cuckle, H., “Biochemical screening for Down syndrome”,Eur. J. Obstet Gynecol Reprod. Biol., 92(1):97-101, 2000.
Dabiri, G.S., “Molecular Cloning of Human Macrophage Capping Protein cDNA. A Unique Member of the Gelsolin/Villin Family Expressed Primarily in Macrophages”,J. Biol. Chem., 267(23):16545-16552, 1992.
Ducsay, C.A., et al., “Simplified Vest and Tether System for Maintenance of Chronically Catheterized Pregnant Rhesus Monkeys”,Lab. Anim. Sci., 38(3):343-344, Jun. 1988.
Duff, P., et al., “The course of labor in term patients with chorioamnionitis”,American Journal of Obstetrics and Gynecology, 147(4):391-395, Oct. 1983.
Gibbs, R.S., et al., “Management of acute chorioamnionitis”,American Journal of Obstetrics and Gynecology, 136(6):709-713, Mar. 1980.
Gilstrap III, L.C., et al., “Intrapartum treatment of acute chorioamnionitis: Impact on neonatal sepsis”,Am. J. Obstet. Gynecol. 159(3):579-583, Sep. 1988.
Goetz, D.H., et al., “The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent that Interferes with Siderophore-Mediated Iron Acquisition”,Mol. Cell, 10(5):1033-1043, 2002.
Gravett, et al., “An experimental model for intraamniotic infection and preterm labor in rhesus monkeys”,Am. J. Obstet. Gynecol., 171(6):1660-7, Dec. 1994.
Grether, J.K., et al., “Maternal Infection and Cerebral Palsy in Infants of Normal Birth Weight”,JAMA278(3):207-211, Jul. 1997.
Gursoy, T., et al., “Preeclampsia Disrupts the Normal Physiology of Leptin”,Am. J. Perinatol, 19(6):303-310, 2002.
Haluska, G.J., et al., “Temporal changes in uterine activity and prostaglandin response to RU486 inRhesus macaquesin late gestation”,Am. J. Obstet. Gynecol, 157:1487-1495, 1987.
Hitti, J., et al., “Amniotic fluid tumor necrosis factor-α and the risk of respiratory distress syndrome among preterm infants”,AM. J. Obstet. Gynecol. 177:50-56, 1997.
Hook, E. B., et al., “The Frequency of Chromosome Abnormalities Detected in Consecutive Newborn Studies-Differences Between Studies-Results by Sex and by Severity of Phenotypic Involvement”, In Hook, E.B., Proter, I.H. (eds.),Population Cytogenetics, pp. 63-79, New York, Academic Press, 1978.
Issaq, J.H., et al., “The SELDI-TOF MS Approach to Proteomins: Protein Profiling and Biomarker Identification”,Biochem. Biophys. Res. Commun., 5:292(3):587-92, 2000.
Jensen, O.N., et al., “Direct observation of UV-crosslinked Protein-Nucleic Acid Complexes by Matrix-assisted Laser Desorption Oonization Mass Spectrometry”,Rapid Commun. Mass. Spectrom., 7:496-501, 1993.
Li, et al., “Proteomics and Bioinformatics Approaches for Identification of Serum Biomarkers to Detect Breast Cancer”,Clinical Chemsitry Journal, 48(8):1296-1304, 2002.
Lomas, D.A., et al., “Serpinopathies and the Conformational Dementias”,Nat. Rev. Genet3:759-768, 2002.
Lopez-Zeno, J.A., et al., “A Controlled Trial of a Program for the Active Management of Labor”,N. Engl. J. Med. 326(7):450-454, Feb. 1992.
Marvin, L., et al., “Identification of proteins from one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis using electrospray quadrupole-time-of-flight tandem mass spectrometry”,Rapid Commun. Mass. Spectrom. 14:1287-1292, 2000.
Meis, P.J., et al.., “Factor associated with preterm birth in Cardiff, Wales: II. Indicated and spontaneous preterm birth”,Am. J. Obstet. Gynecol., 173(2):597-602, Aug. 1995.
Morales, W.J., “The Effect of Chorioamnionitis on the Developmental Outcome of Preterm Infants at One year”,Obstetrics and Gynecology, 70(2):183-186, Aug. 1987.
Newton, E.R., “Chorioamnionitis and Intraamniotic Infection”,Clin. Obstet. Gynecol., 36(4):795-808, Dec. 1993.
Newton, E.R., et al., “Logistic Regression Analysis of Risk Factors for Intra-Amniotic Infection”,Obstet. Gynecol., 73(4):571-575, Apr. 1989.
Ohlsson, A., et al., “An analysis of antenatal tests to detect infection at preterm premature rupture of the membranes”,American Journal of Obstetrics and Gynecology, 162(3):809-818, Mar. 1990.
Pereira, H.A., “CAP37, a neutrophil-derived multifunctional inflammatory mediator”,J. Leukoc Biol. 57:805-812, 1995.
Petricoin, III, E.F., et al., “Use of poteomic patterns in serum to identify ovarian cancer”,The Lancet359:572-77, Feb. 2002.
Romero, R., et al., “The Role of Systemic and Intrauterine Infection in Preterm Parturition”,Annuals of the New York Academy of Science622:355-375, May 1991.
Schweitzer, B., et al., “Measuring proteins on microarrays”,Curr. Opin. Biotechnol., 13:14-9, 2002.
Soper, D.E., et al., “Risk factors for intraamniotic infection: A prospective epidemicologic study”,American Journal of Obstetrics and Gynecology161(3):562-568, Sep. 1989.
Speck, O., et al., “Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity”,Nature421(2):83-87, 2003.
Tabb, D.L., et al., “DTASelect and Contrast: Tools for Assembling and Comparing Protein Identifications from Shotgun Proteomics”,J. Proteome Res. 1:21-26, 2002.
Tang, B.L., “Inhibitors of neuronal regeneration: mediators and signaling mechanisms”,Neurochem. Int., 42(3):189-203, 2003.
Taylor, J.A., et al., “Implementation and Uses of Automated de Novo Peptide Sequencing by Tandem Mass Spectrometry”,Anal. Chem. 73(11):2594-604, 2001.
Thorey, I.S., et al., “The Ca2+-binding Proteins S100A8 and S100A9 Are Encoded by Novel Injury-regulated Genes”,J. Biol. Chem. 276(38):35818-35825, 2001.
Vray, B., et al., “Immunomodulatory properties of cystatins”,Cell Mol. Life Sci., 59:1503-1512, 2002.
Watts, D.H., et al., “The Association of Occult Amniotic Fuid Infection with Gestational Age and Neonatal Outcome
Gravett Mike
Nagalla Sri
Rosenfeld Ron
Brusca John S.
Dreger Ginger R.
Heller Ehrman LLP
Lendaris Steven P.
Proteogenix, Inc.
LandOfFree
Proteomic analysis of biological fluids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteomic analysis of biological fluids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteomic analysis of biological fluids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3761062